|
Volumn 5, Issue 4, 2004, Pages 251-253
|
Octreotide: An active agent in epithelial ovarian carcinoma?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
CAPECITABINE;
CARBOPLATIN;
DEXAMETHASONE;
DIAMORPHINE;
DOXORUBICIN;
METOCLOPRAMIDE;
OCTREOTIDE;
PACLITAXEL;
SCOPOLAMINE;
THYROXINE;
ABDOMINAL HYSTERECTOMY;
ADULT;
ARTICLE;
CANCER RECURRENCE;
CANCER STAGING;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG WITHDRAWAL;
ECHOGRAPHY;
ELECTRON MICROSCOPY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LAPAROTOMY;
OMENTOPLASTY;
OVARIECTOMY;
OVARY CARCINOMA;
PERITONEUM METASTASIS;
PRIORITY JOURNAL;
SALPINGOOOPHORECTOMY;
SMALL INTESTINE OBSTRUCTION;
TREATMENT OUTCOME;
VOMITING;
ANTINEOPLASTIC AGENTS, HORMONAL;
CA-125 ANTIGEN;
CARCINOMA;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INTESTINAL OBSTRUCTION;
MIDDLE AGED;
OCTREOTIDE;
OVARIAN NEOPLASMS;
RECEPTORS, SOMATOSTATIN;
REMISSION, SPONTANEOUS;
VOMITING;
|
EID: 1642265607
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(04)01430-5 Document Type: Article |
Times cited : (10)
|
References (6)
|